<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Expression of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ in the lung tissue of obese mice and the effect of rosiglitazone on proinflammatory cytokine expressions in the lung tissue</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Korean Pediatric Society</publisher>
				<availability status="unknown"><p>Copyright Korean Pediatric Society</p>
				</availability>
				<date type="published" when="2013">2013</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">Seung</forename><forename type="middle">Lok</forename><surname>Ryu</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pediatrics</orgName>
							</affiliation>
						</author>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">Jae</forename><forename type="middle">Won</forename><surname>Shim</surname></persName>
							<email>jy7.shim@samsung.com</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Pediatrics</orgName>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">Duk</forename><forename type="middle">Soo</forename><surname>Kim</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pediatrics</orgName>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hye</forename><forename type="middle">Lim</forename><surname>Jung</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">Moon</forename><forename type="middle">Soo</forename><surname>Park</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pediatrics</orgName>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Soo-Hee</forename><surname>Park</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Medical Research</orgName>
								<orgName type="institution" key="instit1">Kangbuk Samsung Hospital</orgName>
								<orgName type="institution" key="instit2">Sungkyunkwan University School of Medicine</orgName>
								<address>
									<settlement>Seoul</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jinmi</forename><surname>Lee</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Medical Research</orgName>
								<orgName type="institution" key="instit1">Kangbuk Samsung Hospital</orgName>
								<orgName type="institution" key="instit2">Sungkyunkwan University School of Medicine</orgName>
								<address>
									<settlement>Seoul</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">Won-Young</forename><surname>Lee</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Endocrinology and Metabolism</orgName>
								<orgName type="institution" key="instit1">Kangbuk Samsung Hospital</orgName>
								<orgName type="institution" key="instit2">Sungkyunkwan University School of Medicine</orgName>
								<address>
									<settlement>Seoul</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">Jung</forename><forename type="middle">Yeon</forename><surname>Shim</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pediatrics</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="department">Sungkyunkwan University School of Medicine</orgName>
								<orgName type="laboratory">Division of Pediatric Allergy &amp; Pulmonology, De-partment of Pediatrics</orgName>
								<address>
									<addrLine>Kangbuk Samsung Hospi-tal, 29 Saemunan-ro, Jongno-gu</addrLine>
									<postCode>110-746</postCode>
									<settlement>Seoul</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Expression of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ in the lung tissue of obese mice and the effect of rosiglitazone on proinflammatory cytokine expressions in the lung tissue</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Korean Journal of Pediatrics</title>
						<title level="j" type="abbrev">Korean J Pediatr</title>
						<idno type="ISSN">1738-1061</idno>
						<idno type="eISSN">2092-7258</idno>
						<imprint>
							<publisher>Korean Pediatric Society</publisher>
							<biblScope unit="volume">56</biblScope>
							<biblScope unit="issue">4</biblScope>
							<biblScope unit="page">151</biblScope>
							<date type="published" when="2013" />
						</imprint>
					</monogr>
					<idno type="DOI">10.3345/kjp.2013.56.4.151</idno>
					<idno type="PMID">23646053</idno>
					<idno type="PMCID">PMC3641311</idno>
					<note type="submission">Received: 29 August 2012 Revised: 23 October 2012 Accepted: 24 October 2012</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T23:46+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Peroxisome proliferator-activated receptors</term>
					<term>Obesity</term>
					<term>Transforming growth factor-beta</term>
					<term>Vascularendothelial growth factor</term>
					<term>Tumor necrosis factor-alpha</term>
				</keywords>
			</textClass>
			<abstract>
				<p>We investigated the mRNA levels of peroxisome proliferator-activated receptor (PPAR)-α, PPAR-γ, adipokines, and cytokines in the lung tissue of lean and obese mice with and without ovalbumin (OVA) challenge, and the effect of rosiglitazone, a PPAR-γ agonist. Methods: We developed 6 mice models: OVA-challenged lean mice with and without rosiglitazone; obese mice with and without rosiglitazone; and OVA-challenged obese mice with and without rosiglitazone. We performed real-time polymerase chain reaction for leptin, leptin receptor, adiponectin, vascular endothelial growth factor (VEGF), tumor necrosis factor (TNF)-α, transforming growth factor (TGF)-β, PPAR-α and PPAR-γ from the lung tissue and determined the cell counts and cytokine levels in the bronchoalveolar lavage fluid. Results: Mice with OVA challenge showed airway hyperresponsiveness. The lung mRNA levels of PPARα and PPAR-γ increased significantly in obese mice with OVA challenge compared to that in other types of mice and decreased after rosiglitazone administeration. Leptin and leptin receptor expression increased in obese mice with and without OVA challenge and decreased following rosiglitazone treatment. Adiponectin mRNA level increased in lean mice with OVA challenge. Lung VEGF, TNF-α, and TGF-β mRNA levels increased in obese mice with and without OVA challenge compared to that in the control mice. However, rosiglitazone reduced only TGF-β expression in obese mice, and even augmented VEGF expression in all types of mice. Rosiglitazone treatment did not reduce airway responsiveness, but increased neutrophils and macrophages in the bronchoalveolar lavage fluid. Conclusion: PPAR-α and PPAR-γ expressions were upregulated in the lung tissue of OVA-challenged obese mice however, rosiglitazone treatment did not downregulate airway inflammation in these mice.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Expression of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ in the lung tissue of obese mice and the effect of rosiglitazone on proinflammatory cytokine expressions in the lung tissue Introduction Epidemiological data show an increased incidence of asthma in overweight or obese children and adults. The relative risk of incident asthma increases with increasing body mass, which has been associated with enhancement of asthma symptoms, airway hyperresponsiveness (AHR) and atopy <ref type="bibr" target="#b0">1)</ref> . Obesity is particularly important for severe asthma because more than 75% of asth matic individuals visiting the emergency room are obese or overweight <ref type="bibr" target="#b0">1)</ref> . Obesity may be related to the steroidresistant asthma.</p><p>Consumption of a highfat diet has been shown to lead to lipid accumulation and inflammatory signaling in key neuronal subsets involved in the regulation of biochemical resistance to insulin, leptin, and other regulatory hormones and nutrient signals <ref type="bibr" target="#b1">2)</ref> .</p><p>In order to understand the effect of dietary fat on obesity predisposition, we sought to identify molecular metabolic regulators that may be lipid sensitive. Peroxisome proliferator activated receptor (PPAR) γ is member of the PPAR family of nuclear receptors, a class of lipid activated transcription factors belonging to the nuclear receptor superfamily <ref type="bibr" target="#b1">2)</ref> .</p><p>Current evidence suggests that obesity related changes in the production of adiposederived cytokines, adipokines, may modulate asthma. Alterations in the production of the adipo kines such asleptin and adiponectin could play a critical role in mediating airway inflammation and AHR <ref type="bibr" target="#b2">3)</ref> .</p><p>PPARs are a family of ligandactivated transcription factors belonging to the nuclear hormone receptor family and related to retinoid, glucocorticoid, and thyroid hormone receptors <ref type="bibr" target="#b3">4)</ref> . The presence of PPARs has been demonstrated in a variety of cells associated with lung inflammation <ref type="bibr" target="#b4">5)</ref> . The widespread dis tribution of PPAR in the airway suggests that they may play important roles in both lung health and disease <ref type="bibr" target="#b5">6)</ref> .</p><p>PPARs can be involved in the inflammatory cascade of asth ma, and treatment with PPAR agonists may reduce airway in flammation <ref type="bibr" target="#b3">4)</ref> . The activation of PPAR γ and PPARα is thought to downregulate proinflammatory gene expression and inflam matory cell functions <ref type="bibr" target="#b3">4)</ref> . PPAR γ ligands inhibit the release of proinflammatory cytokines from activated macroph ages, airway epithelial cells, and eosinophils, and decrease AHR, basement membrane thickness, collagen deposition, and eosinophilia in murine models of asthma <ref type="bibr" target="#b6">7)</ref> .</p><p>There have been a few studies for the effect of PPAR γ agonist on airway inflammation in asthmatics, however there is no data on obesity, especially on obese asthma. The presents study aimed to compare the mRNA levels of lung PPAR γ and PPARα among lean and obese mice with and without ovalbumin (OVA) challenge and investigate the effect of rosiglitazone on cytokines related to airway inflammation and airway respon siveness.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods</head><p>We developed a mouse model of chronic asthma with or without obesity. Mice were divided into 7 groups: control group, lean OVAchallenged groups with (A) and without (B) rosiglitazone, obese groups with (C) and without (D) rosiglitazone, and obese OVAchallenged groups with (E) and without (F) rosiglitazone. Each group was comprised of 6 mice. The animal experimental protocol was approved by the Animal Subjects Committee.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Sensitization and antigen challenge protocol</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>1) Obese model</head><p>Sixweekold female C57BL/6J mice (Central Lab. Animal Inc., Seoul, Korea) were fed a highfat diet in which 45% of the calories are derived from fat (Feedlab, Guri, Korea) for a period of 16 weeks. Food intake and body weight were measured every 7 days during the study period. Mice were allowed free access to water and food and housed 4 per cage in a temperaturecontrolled room with a 12:12hour lightdark cycle. Nonobese mice were given a standard diet. Rosiglitazone was administered with diet in 0.01% concentration.</p><p>2) Chronic asthma model Sixweekold female C57BL/6J mice were immunized by subcutaneous injection on days 0, 7, 14, and 21 with 25 μg of OVA (grade V; SigmaAldrich Co., St. Louis, MO, USA) adsorbed to 1 mg of aluminum hydroxide (SigmaAldrich Co.) in 200 μL of phosphatebuffered saline (PBS). Intranasal OVA challenges (20 μg/50 μL in PBS) were administered on days 27, 29, and 31 under isoflurane anesthesia. Intranasal OVA challenges were repeated twice per week until week 18 of the study period. Age and sexmatched control mice were treated the same way with PBS but without OVA. Mice were sacrificed 24 hours after the final OVA challenge, and bronchoalveolar lavage (BAL) and lung tissues were obtained.</p><p>3) Measurement of AHR AHR was assessed by a singlechamber wholebody plethys mograph (Allmedicus, Anyang, Korea). The enhanced pause (Penh) was used to monitor airway responsiveness. In the plethysmograph, mice were exposed for 3 minutes to nebulized PBS to establish baseline Penh values, and were subsequently exposed to increasing concentrations of nebulized methacholine (3-50 mg/mL; SigmaAldrich Co.) in PBS using an Aerosonic ultrasonic nebulizer (DeVilbiss, Somerset, PA, USA). Following each nebulization, recordings were taken for 3 minutes. The Penh values measured during each 3minute sequence were averaged and are expressed for each methacholine concentration.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>4) Analysis of cells in BAL fluid</head><p>Mice were sacrificed after measuring AHR. The trachea was exposed and cannulated with silicone tubing attached to a 23gauge needle on a 1 mL syringe. After the instillation of 1 mL of sterile PBS into the lung, the BAL fluid was withdrawn. The BAL fluid was stained with a hematology analyzer, XE2100 (Sysmex, Kobe, Japan) after cytospinning (7 minutes at 2,000 rpm). Total cell count was performed using a hemacyto meter.</p><p>Korean J Pediatr 2013;56(4):151-158</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Data analysis</head><p>Results for each group were compared by analysis of variance, followed by Dunn's multiple comparison of means. SPSS ver. 10.0 (SPSS Inc., Chicago, IL, USA) was used for analysis. A P value of &lt;0.05 was considered statistically significant. All results are given as mean±standard error of the mean.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Effect of high-fat diet on body weight</head><p>Obese groups fed 45% highfat diet with and without OVA challenge weighed significantly more than other groups fed a normal diet. At the end of the study, mice in group C and D reached 27.8 g and 27.7 g, while control mice weighted 22.5 g, and 23% (9.6 g weight gain) and 24% (9.9 g weight gain) more weight gain than that of control group (4.5 g weight gain), respectively (P&lt;0.05). Groups E and F gained more weight by 16% (8.3 g weight gain) and 14% (7.7 g weight gain) compared to control group, respectively (P&lt;0.05). Groups A and B mice showedno difference in weight (4.5 g and 2.7 g weight gain, re spectively) compared to control mice ( <ref type="figure">Fig. 1</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Airway inflammation</head><p>Total cell numbers and macrophage numbers in BAL fluid increased significantly in groups A to F mice compared to the control group (P&lt;0.05). Groups A, B, E, and F mice also showed a significant increase in total cell and macrophage numbers compared to groups C and D mice (P&lt;0.05). Groups A, B, E and After counting 400 leukocytes on the slide by light microscopy, the percentage of eosinophils, neutrophils, lym phocytes, and macrophages were calculated. Supernatants were stored at 70℃.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>5) Analysis of vascular endothelial growth factor (VEGF) and transforming growth factor (TGF)-β in BAL fluid</head><p>VEGF and TGFβ concentrations were measured using enzyme linked immunosorbent assay kit (R&amp;D, Minneapolis, MN, USA) in BAL fluid according to the manufacturer's in structions.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>6) RNA isolation and real-time reverse transcription-polymerase chain reaction (RT-PCR)</head><p>Lung tissues were analyzed by realtime PCR for leptin, leptin receptor, adiponectin, adiponectin receptor (Adipor1 &amp; Adipor2), VEGF, TGFβ, and TNFα. Total RNA was isolated from lung tissue using Trizol reagent (Invitrogen, Carlsbad, CA, USA). Total RNA, at a concentration of 2 μg, was reversetranscribed with Moloney murine leukemia virus reverse transcriptase (MMLVRT) and oligo <ref type="bibr" target="#b7">8)</ref> 12-18 primer (Invitrogen), to generate cDNA. Briefly, RNA was denatured for 10 minutes at 72℃, then immediately placed on ice for 5 minutes. Denatured RNA was mixed with MMLVRT, MMLVRT buffer, and dNTP mixture, and incubated for 1 hour at 42℃. The reagent was inactivated by heating at 95℃ for 2 minutes. Synthesized cDNA was am plified by realtime PCR (LightCycler 480, Roche, Lewis, UK) using SYBR green (Invi trogen) and specific primers (Bioneer Co., Daejon, Korea). The following primers were used: leptin, forward: 5'TGGCTTTG GTCCTATCTGTC3', re verse: 5' TCCTGGTGACAATGGTCTTG3' (GenBank ac ce ssion number: BC125245); leptin receptor, forward: 5'TGTCTCAGCTACATCTCTGC3', reverse: 5'CTGAACCATCCA GTCTCTTG3' (GenBank accession number: BC082551); adiponec tin, forward: 5'AGAGAAAGGAGATGCAGGTC3', reverse: 5'TGAACGCT GAGCGATACACA3' (GenBank accession number: NM009605); Adipor1, forward: 5'AGATGGGCTGGTTCTT CCTC 3', reverse: 5'CAGACAACTCAGACTCTTCC3' (GenBank accession num ber: NM1283203); Adipor2, forward: 5'ATGTTTGCCACC CCTCAGTA3', reverse: 5'CAGATGTCACATTTGCCAGG3' (GenBank accession number: NM197985); VEGF, forward: 5' GTGGACATCTTCCAGGAGTA3', reverse: 5'TTCATCGTTACAG CAGCCTG3' (GenBank accession number: BC061468); TGF, forward: 5'AGTGTGGAGCAACATGTGGA3', reverse: 5'GTAC AACTCCAGTGACGTCA3' (GenBank accession number: BC013738); TNFα, : 5'CGCTCTTCTGTCTACTGAAC3', reverse: 5'CTACAGGCTTGTCACTCGAA3' (GenBank accession num ber: NM013693). Each cycle consisted of denaturation at 94℃ for 15 seconds, annealing at 55℃ for 10 seconds, and extension at 72℃ for 20 seconds. Quantification was performed using the com parative 2(delta delta Ct) method; expression levels for the target genes were normalized to the βactin of each sample. <ref type="figure">Fig. 1</ref>. Effect of high-fat diet on body mass. Mice fed a high-fat diet (groups C, D, E, and F) weighed significantly more than control mice, whereas mice fed a normal diet (groups A and B) showed no difference in weight compared to control mice at after 18 weeks of the study period. Group A, lean mice with ovalbumin (OVA) challenge; group B, rosiglitazone-treated lean mice with OVA challenge; group C, obese mice without OVA challenge; group D, rosiglitazone-treated obese mice without OVA challenge; group E, obese mice with OVA challenge; and group F, rosiglitazone-treated obese mice with OVA challenge.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Weight (g)</head><p>Leptin and leptin receptor mRNA levels increased in groups C and E mice compared to control mice, and rosiglitazone de creased leptin and leptin receptor mRNA levels in both mice (groups D and F). However, administration of rosiglitazone showed increased expression of leptin and leptin receptor mRNA levels in group B mice compared to group A mice.</p><p>Adiponectin mRNA levels increased significantly in group A mice compared to control mice and showed a tendency of F mice had significantly increased number of eosinophils in the BAL fluid compared to those in the control group (P&lt;0.05), whereas groups C and D mice showed no significant increase in eosinophils compared to control group. Mice in groups C, D, E, and F showed significant increases in neutrophil numbers in BAL fluid compared to control mice (P&lt;0.05). Rosiglitazone treatment didn't affect cell numbers in BAL fluid compared to notreatment in each group <ref type="figure" target="#fig_0">(Fig. 2</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">AHR to methacholine</head><p>Increasing doses of methacholine induced an increase in airway resistance in all types of mice. The Penh increase was higher in groups A, B, E and F mice than in control mice, re vealing the induction of AHR in OVAchallenged mice. How ever, groups C and D mice didn't show AHR. Rosiglitazone treatment did not affect AHR in each type of mice with no ro siglitazone treatment <ref type="figure">(Fig. 3</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Expression of PPAR-α, PPAR-γ , leptin, leptin receptor and adiponectin mRNA in lung tissue of mice</head><p>To assess the effect of obesity on lung inflammation and expression of adipokines in mice, we measured mRNA levels of PPARα, PPAR γ , leptin, leptin receptor, adiponectin, adipo nectin receptor, VEGF, TNFα and TGFβ in lung tissue of mice by real time PCR.</p><p>Expression of PPARα and PPAR γ increased significantly in group E mice compared to control mice, which decreased signifi cantly when rosiglitazone was treated (group F). There were no differences in PPARα and PPAR γ expressions in groups A, B, C, and D mice compared to control mice <ref type="figure">(Fig. 4A)</ref>.  decrease in group C mice. Administration of rosiglitazone in creased adiponectin mRNA levels in group D mice compared to group C mice, while it showed decreased tendency in group B mice compared to group A mice <ref type="figure">(Fig. 4B)</ref>.</p><p>5. VEGF, TNF-α, and TGF-β levels in BAL fluid and mRNA expression in lung tissue of mice VEGF mRNA levels increased significantly in groups A, C, and E mice compared to control mice, which augmented more when rosiglitazone was administered (groups B, D, and F, respectively) compared to no rosiglitazone treatment. Lung mRNA levels of TNFα and TGFβ increased significantly in groups C and E mice compared to control mice. Rosiglitazone also increased TNFα mRNA levels in group F mice compared to group E mice, however decreased TGFβ mRNA levels in group D mice compared to group C mice (P&lt;0.05) <ref type="figure">(Fig. 5A)</ref>.</p><p>VEGF levels in BAL fluid were also higher in groups A, C, and E mice than in control mice, which increased significantly in rosiglitazonetreated mice (groups B, D, and F, respectively). Concentration of TGFβ in BAL fluid augmented in groups C and E mice compared to control mice, which decreased signifi cantly in group D mice compared to group C mice <ref type="figure">(Fig. 5B, C)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>We compared PPAR γ and PPARα mRNA levels in lung tissue of mice with OVA challenge and/or obesity, and also investigated the effect of rosiglitazone on lung expressions of PPAR γ and PPARα. PPAR γ and PPARα mRNA levels increased significantly in obese mice with OVA challenge compared to lean mice with OVA challenge and obese mice as well as control mice, and decreased significantly when rosigli tazone was treated.</p><p>PPAR γ has been suggested as an indicator of airway inflam mation and remodeling in asthma <ref type="bibr" target="#b8">9)</ref> . A study indicated a positive correlation between PPAR γ expression and airway remodeling in asthma such as subbasement membrane thickening, collagen deposition, and increase of proliferating cells in the epithelium and submucosa area <ref type="bibr" target="#b9">10)</ref> . Intensity of PPAR γ expression in the bronchial submucosa, the airway epithelium and the smooth muscle also showed negative correlation with the forced expir atory volume values. Furthermore, steroids restrained PPAR γ expression in lung tissue <ref type="bibr" target="#b9">10)</ref> . Expression of PPAR γ is also related to obesity. In our previous study, PPAR γ expression also increased in obese rat <ref type="bibr" target="#b10">11)</ref> . We found PPAR γ mRNA level was higher in obese mice with OVA challenge than obese mice or lean mice with OVA challenge, which suggests synergistic effect of obesity and asthma on PPAR γ expression. To our knowledge, there has been no report that investigated PPAR γ and PPARα expressions in obese mice with OVA challenge.</p><p>Asthma is a chronic inflammatory airway disease, and obe sity also represents a lowgrade chronic inflammatory state. Considering obese patients have more difficulties in controlling asthma and decreased responsiveness to inhaled corticosteroid <ref type="bibr" target="#b11">12)</ref> , PPAR γ or PPARα agonist can be a good can didate for controll ing difficult asthma in obese asthmatics.</p><p>There are a few clinical studies for the therapeutic effect of PPAR γ ligands in asthma. Pioglitazone improved wheezing and coughing in patients with asthma, and asthma symptoms restarted when the pioglitazone treatment was discontinued <ref type="bibr" target="#b12">13)</ref> . Another study shows that rosiglitazone improved lung function, compared with inhaled corticosteroid in steroidresistant smoker with asthma <ref type="bibr" target="#b13">14)</ref> , and PPAR γ agonists reduced the asthma symp toms and levels of Th2 cytokines, adhesion molecules, chemokines, and TGFβ1 in toluene diisocyanateinduced asthma <ref type="bibr" target="#b14">15)</ref> . On the contrary, PPAR γ genetic expression has been shown to be reduced in asthmatic patients after an allergen <ref type="figure">Fig. 4</ref>. ThemRNA levels of peroxisome proliferator-activated receptor (PPAR)γ , PPAR-α, leptin, leptin receptor, and adiponectinin the lung tissue of mice and the effect of rosiglitazone treatment. Expression of PPAR-α and PPAR-γ increased significantly in group E mice compared to that in control mice, and it decreased significantly with rosiglitazone treatment in group F mice (A). Leptin and leptin receptor increased significantly in the mice in groups C and E compared to that in control mice, and these decreased significantly with rosiglitazone treatment. Adiponectin increased significantly in group A mice compared to that in control mice, and rosiglitazone augmented adiponectin mRNA level in group D mice compared to that in group C mice (B). Group A, lean mice with ovalbumin (OVA) challenge; Group B, rosiglitazone-treated lean mice with OVA challenge; Group C, obese mice without OVA challenge; Group D, rosiglitazone-treated obese mice without OVA challenge; Group E, obese mice with OVA challenge; and Group F, rosiglitazone-treated obese mice with OVA challenge. *P&lt;0.05 vs. control. † P&lt;0.05 vs. each group of mice without rosiglitazone treatment. challenge, and inversely related to airway inflammation <ref type="bibr" target="#b15">16)</ref> . In mature adipocytes, PPAR γ interacts with several coactivators with chromatin modifying activities, repress and enhance its transcriptional activity <ref type="bibr" target="#b16">17)</ref> . Although PPAR γ and PPARα lung expressions didn't increase significantly in mice with OVA challenge and with obesity, we found a tendency of in crease. As a result, rosiglitazone administration decreased the lung PPAR γ and PPARα mRNA levels in mice with OVA challenge. We can figure out the possibility of significance with the increase of study subjects in the future study. The direct mechanism for the relationship between obesity and asthma has not been established yet. Leptin is a hormone secreted preferentially by adipose tissue, exerting pleiotropic effects such as body weight homeostasis, reproduction and hematopoiesis <ref type="bibr" target="#b17">18)</ref> . Leptin acts as a proinflammatory cytokine, and its blood level is elevated in obese people. Leptin receptor is expressed in airway smooth muscle <ref type="bibr" target="#b18">19)</ref> , and leptin promoted VEGF release by human airway smooth muscle cells <ref type="bibr" target="#b19">20)</ref> . In this study, leptin as well as leptin receptor demonstrated increased mRNA levels in obese mice with and without OVA challenge, which decreased with rosiglitazone. However, they didn't show significant increase in mice with OVA challenge compared to control mice, and there was no difference in the expression of leptin and leptin receptor between obese mice with and without OVA challenge. Rosiglitazone administration to the preadipocytes isolated from obese mice, resulted in the diffe rentiation into mature adipo cytes. The inhibitory effect of leptin on rosiglitazone induced adipocyte differentiation was also accompanied by the decreased expression of adipogenic transcription factors. Rosiglitazone was decreased in the presence of leptin <ref type="bibr" target="#b17">18)</ref> . Leptin may be related to obesity itself, not asthma, and may not be a contributing factor for poorly controlled asthma in obese asthmatics. There has been no data onthe effect of rosiglitazone on leptin regulation in asthma. Contrary to our study, another study demonstrated rosiglitazone increased leptin levels in obese mice, while decreased leptin levels in lean mice <ref type="bibr" target="#b2">3)</ref> . However, they tried short <ref type="figure">Fig. 5</ref>. The mRNA levels of vascular endothelial growth factor (VEGF), transforming growth factor (TGF)-β, and tumor necrosis factor (TNF)-α in the lung tissue of mice and the effect of rosiglitazone in the bronchoalveolar lavage (BAL) fluid. VEGF expression in the lung increased significantly in the mice in groups A, C, and E and was augmented significantly after rosiglitazone treatment. TNF-α and TGF-β expression in the mice in groups C and E increased significantly compared to that in control mice. TNF-α expression was augmented with rosiglitazone treatment in group F mice compared to that in group E mice, while TGF-β expression decreased significantly in group D mice compared to that in group C mice (A). VEGF concentration in the BAL fluid was higher in the mice in groups A, C, and E than in control mice and increased significantly in each group of mice with rosiglitazone treatment (groups B, D, and F). TGF-β level in the BAL fluid was higher in the mice groups C and E than in control mice and decreased signifi cantly in group D mice with rosiglitazone treatment (B and C). Group A, lean mice with ovalbumin (OVA) challenge; group B, rosiglitazone-treated lean mice with OVA challenge; group C, obese mice without OVA challenge; group D, rosiglitazone-treated obese mice without OVA challenge; group E, obese mice with OVA challenge; and group F, rosiglitazone-treated obese mice with OVA challenge. *P&lt;0.05 vs. control. † P&lt;0.05 vs. each group of mice without rosiglitazone treatment. Adiponectin may play an antiinflammatory role in obesity related diseases <ref type="bibr" target="#b20">21)</ref> . Adiponectin receptors are expressed in airway smooth muscle <ref type="bibr" target="#b19">20)</ref> . In this study, lung expression of adiponectin increased significantly in mice with OVA challenge, and decreased in obese mice. However, there was no significant difference in obese mice with OVA challenge compared to control mice. Until now, there has been no data which investi gated the lung expression of adiponectin in obese mice with OVA challenge. Lung adiponectin may not be a major factor to regulate the airway inflammation in obese asthmatics.</p><p>Proinflammatory cytokines such as TNF, TGF, and VEGF are increased in obesity. They are also an important cytokines in regulating airway inflammation in asthma <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b22">23)</ref> . We found augmented lung expression of VEGF, TNFα, and TGFβ in both obese mice with and without OVA challenge, and VEGF mRNA level also increased in lean mice with OVA challenge. However, there was no synergistic increase of cytokine expressions in obese mice with OVA challenge compared to lean mice with OVA challenge or obese mice. In this study, rosiglitazone enhanced lung VEGF mRNA level in all types of mice, and TNFα mRNA level in obese mice with OVA chal lenge. This is supported by another study with murine model with chronic asthma, which shows increased VEGF and TGFβ levels in BAL fluid of ciglitazonetreated asthma mice <ref type="bibr" target="#b23">24)</ref> . However, other studies showed PPAR agonists decreased serum VEGF levels and lung expression of TGFβ <ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b24">25)</ref> , and reduced expression of TNFα in adipocytes ofobese mice treated with the PPAR γ agonist troglitazone <ref type="bibr" target="#b25">26)</ref> . We can assume VEGF, TNFα, and TGFβ are not major contributing cytokines regulated by rosiglitazone in obese asthmatics. There has been no data on the effect of rosiglitazone on cytokine expressions in obese asthmatics.</p><p>This study was limited by relatively small number of subjects and no measurement of AHR and airway inflammation. How ever, this is the same method to develop chronic asthma model in mice <ref type="bibr" target="#b23">24)</ref> . And we administered rosiglitazone into the diet, not into the airway. The method and type of PPAR γ agonist as well as the duration of administration can make difference. However, there has been only a few studies using murine model of obese asthmatics, and to our knowledge, this is the first study comparing lung expression of PPAR, adipokines, and cytokines according to obesity and OVA challenge.</p><p>Taken together, this study suggests that PPARα and PPAR γ lung expression is augmented in obese mice with OVA challenge, and PPAR γ agonist dose not downregulate VEGF, TNFα, and TGFβ expressions in lung tissue of obese asthma.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 2 .</head><label>2</label><figDesc>Effect of obesity and ovalbumin (OVA) challenge on total and differential cell counts in the bronchoalveolar lavage (BAL) fluid. The mice in groups A, B, E, and F showed a significant increase in the numbers of total cells, eosinophils, and macrophages compared to control mice and mice in groups C and D. Com pared to the control group, the mice in groups C and D showed increased numbers in total cell and macrophage counts, but not in the number of eosinophils.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc>treatment of rosiglitazone on airway as opposed to 18 weeks administration in this study.</figDesc></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p>This study was supported by Kangbuk Samsung Hospital Medical Research Fund.</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of interest</head><p>No potential conflict of interest relevant to this article was reported.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Obesity enhances eosinophilic inflammation in a murine model of allergic asthma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Calixto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Lintomen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Schenka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Saad</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Zanesco</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Antunes</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1476-5381.2009.00560.x</idno>
		<idno type="PMID">20100278</idno>
		<idno type="PMCID">PMC2828025</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2828025?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">British Journal of Pharmacology</title>
		<idno type="ISSN">0007-1188</idno>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="617" to="625" />
			<date type="published" when="2010-01-22" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Neuron-Specific Deletion of Peroxisome Proliferator-Activated Receptor Delta (PPARδ) in Mice Leads to Increased Susceptibility to Diet-Induced Obesity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Heidi</forename><forename type="middle">E</forename><surname>Kocalis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maxine</forename><forename type="middle">K</forename><surname>Turney</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">L</forename><surname>Printz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gloria</forename><forename type="middle">N</forename><surname>Laryea</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Louis</forename><forename type="middle">J</forename><surname>Muglia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sean</forename><forename type="middle">S</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gregg</forename><forename type="middle">D</forename><surname>Stanwood</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Owen</forename><forename type="middle">P</forename><surname>Mcguinness</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kevin</forename><forename type="middle">D</forename><surname>Niswender</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0042981</idno>
		<idno type="PMID">22916190</idno>
		<idno type="PMCID">PMC3423438</idno>
		<ptr type="open-access" target="https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0042981&amp;type=printable" />
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<title level="j" type="abbrev">PLoS ONE</title>
		<idno type="ISSNe">1932-6203</idno>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">e42981</biblScope>
			<date type="published" when="2012-08-20" />
			<publisher>Public Library of Science (PLoS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">The Peroxisome Proliferator Activated Receptor Gamma (PPARγ) Ligand Rosiglitazone Modulates Bronchoalveolar Lavage Levels of Leptin, Adiponectin, and Inflammatory Cytokines in Lean and Obese Mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fernando</forename><surname>Holguin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mauricio</forename><surname>Rojas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">Michael</forename><surname>Hart</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00408-007-9035-9</idno>
		<idno type="PMID">17909895</idno>
		<idno type="ark">ark:/67375/VQC-9LG4WDD5-D</idno>
		<idno type="istexId">90F79324DF70D4A55AB50DB615D0CD4B958AC499</idno>
	</analytic>
	<monogr>
		<title level="j">Lung</title>
		<title level="j" type="abbrev">Lung</title>
		<idno type="ISSN">0341-2040</idno>
		<idno type="ISSNe">1432-1750</idno>
		<imprint>
			<biblScope unit="volume">185</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="367" to="372" />
			<date type="published" when="2007-10-02" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maria</forename><forename type="middle">G</forename><surname>Belvisi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jane</forename><forename type="middle">A</forename><surname>Mitchell</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1476-5381.2009.00373.x</idno>
		<idno type="PMID">19703165</idno>
		<idno type="PMCID">PMC2785522</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2785522?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">British Journal of Pharmacology</title>
		<idno type="ISSN">0007-1188</idno>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="994" to="1003" />
			<date type="published" when="2009-08-24" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Peroxisome Proliferator-Activated Receptors as Novel Targets in Lung Disease*</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maria</forename><forename type="middle">G</forename><surname>Belvisi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">J</forename><surname>Hele</surname></persName>
		</author>
		<idno type="DOI">10.1378/chest.07-0019</idno>
		<idno type="PMID">18628217</idno>
	</analytic>
	<monogr>
		<title level="j">Chest</title>
		<title level="j" type="abbrev">Chest</title>
		<idno type="ISSN">0012-3692</idno>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="152" to="157" />
			<date type="published" when="2008-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Peroxisome Proliferator-Activated Receptors: Potential Therapeutic Targets in Lung Disease?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gerene</forename><forename type="middle">M</forename><surname>Denning</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lynn</forename><forename type="middle">L</forename><surname>Stoll</surname></persName>
		</author>
		<idno type="DOI">10.1002/ppul.20338</idno>
		<idno type="PMID">16267824</idno>
		<idno type="ark">ark:/67375/WNG-S9ZBWDNL-8</idno>
		<idno type="istexId">7C89AD81E13580144CBF16A7B2FA26F68EF90761</idno>
	</analytic>
	<monogr>
		<title level="j">Pediatric Pulmonology</title>
		<title level="j" type="abbrev">Pediatr. Pulmonol.</title>
		<idno type="ISSN">8755-6863</idno>
		<idno type="ISSNe">1099-0496</idno>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="23" to="34" />
			<date type="published" when="2005" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Peroxisome proliferator?activated receptor $gamma; is expressed in airways and inhibits features of airway remodeling in a mouse asthma model*1</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Honda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Marquillies</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Capron</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Dombrowicz</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0091-6749(04)01068-1</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Allergy and Clinical Immunology</title>
		<title level="j" type="abbrev">Journal of Allergy and Clinical Immunology</title>
		<idno type="ISSN">0091-6749</idno>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="882" to="888" />
			<date type="published" when="2004-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Leptin Induces Insulin-like Signaling That Antagonizes cAMP Elevation by Glucagon in Hepatocytes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Allan</forename><forename type="middle">Z</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michi</forename><forename type="middle">M</forename><surname>Shinohara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daming</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masami</forename><surname>Shimizu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hagit</forename><surname>Eldar-Finkelman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Edwin</forename><forename type="middle">G</forename><surname>Krebs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joseph</forename><forename type="middle">A</forename><surname>Beavo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Karin</forename><forename type="middle">E</forename><surname>Bornfeldt</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.275.15.11348</idno>
		<idno type="PMID">10753948</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/275/15/11348.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="11348" to="11354" />
			<date type="published" when="2000-04-06" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">The pathophysiological function of peroxisome proliferator-activated receptor-γ in lung-related diseases</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tom Hsun-Wei</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Valentina</forename><surname>Razmovski-Naumovski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bhavani</forename><forename type="middle">Prasad</forename><surname>Kota</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Diana Shu-Hsuan</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Basil</forename><forename type="middle">D</forename><surname>Roufogalis</surname></persName>
		</author>
		<idno type="DOI">10.1186/1465-9921-6-102</idno>
		<idno type="PMID">16153299</idno>
		<idno type="PMCID">PMC1242255</idno>
	</analytic>
	<monogr>
		<title level="j">Respiratory Research</title>
		<title level="j" type="abbrev">Respir Res</title>
		<idno type="ISSNe">1465-993X</idno>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">102</biblScope>
			<date type="published" when="2005-09-09" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Regulation of Peroxisome Proliferator-activated Receptor γ Expression in Human Asthmatic Airways</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Laurent</forename><surname>Benayoun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Séverine</forename><surname>Letuve</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anne</forename><surname>Druilhe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jorge</forename><surname>Boczkowski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marie-Christine</forename><surname>Dombret</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patricia</forename><surname>Mechighel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jérôme</forename><surname>Megret</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guy</forename><surname>Leseche</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michel</forename><surname>Aubier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marina</forename><surname>Pretolani</surname></persName>
		</author>
		<idno type="DOI">10.1164/ajrccm.164.8.2101070</idno>
		<idno type="PMID">11704601</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Respiratory and Critical Care Medicine</title>
		<title level="j" type="abbrev">Am J Respir Crit Care Med</title>
		<idno type="ISSN">1073-449X</idno>
		<idno type="ISSNe">1535-4970</idno>
		<imprint>
			<biblScope unit="volume">164</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1487" to="1494" />
			<date type="published" when="2001-10-15" />
			<publisher>American Thoracic Society</publisher>
		</imprint>
	</monogr>
	<note>Pt 1</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Peroxisome Proliferator-Activated Receptor-Gamma Expression in the Lung Tissue of Obese Rats</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Su</forename><forename type="middle">Jin</forename><surname>Hwang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jung</forename><forename type="middle">Ho</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jae</forename><forename type="middle">Won</forename><surname>Shim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Duk</forename><forename type="middle">Soo</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hye</forename><forename type="middle">Lim</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Moon</forename><forename type="middle">Soo</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Won</forename><forename type="middle">Young</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Se-Yeon</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jung</forename><forename type="middle">Yeon</forename><surname>Shim</surname></persName>
		</author>
		<idno type="DOI">10.3349/ymj.2011.52.3.495</idno>
		<idno type="PMID">21488194</idno>
		<idno type="PMCID">PMC3101042</idno>
		<ptr type="open-access" target="http://synapse.koreamed.org/Synapse/Data/PDFData/0069YMJ/ymj-52-495.pdf" />
	</analytic>
	<monogr>
		<title level="j">Yonsei Medical Journal</title>
		<title level="j" type="abbrev">Yonsei Med J</title>
		<idno type="ISSN">0513-5796</idno>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">495</biblScope>
			<date type="published" when="2011" />
			<publisher>Yonsei University College of Medicine (KAMJE)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wendy</forename><forename type="middle">C</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Deborah</forename><forename type="middle">A</forename><surname>Meyers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sally</forename><forename type="middle">E</forename><surname>Wenzel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">Gerald</forename><surname>Teague</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Huashi</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xingnan</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ralph</forename><surname>D'agostino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mario</forename><surname>Castro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Douglas</forename><surname>Curran-Everett</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anne</forename><forename type="middle">M</forename><surname>Fitzpatrick</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Benjamin</forename><surname>Gaston</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nizar</forename><forename type="middle">N</forename><surname>Jarjour</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ronald</forename><surname>Sorkness</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">J</forename><surname>Calhoun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kian</forename><forename type="middle">Fan</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Suzy</forename><forename type="middle">A A</forename><surname>Comhair</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Raed</forename><forename type="middle">A</forename><surname>Dweik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elliot</forename><surname>Israel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephen</forename><forename type="middle">P</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">W</forename><surname>Busse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Serpil</forename><forename type="middle">C</forename><surname>Erzurum</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eugene</forename><forename type="middle">R</forename><surname>Bleecker</surname></persName>
		</author>
		<idno type="DOI">10.1164/rccm.200906-0896oc</idno>
		<idno type="PMID">19892860</idno>
		<idno type="PMCID">PMC2822971</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2822971?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">American Journal of Respiratory and Critical Care Medicine</title>
		<title level="j" type="abbrev">Am J Respir Crit Care Med</title>
		<idno type="ISSN">1073-449X</idno>
		<idno type="ISSNe">1535-4970</idno>
		<imprint>
			<biblScope unit="volume">181</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="315" to="323" />
			<date type="published" when="2010-02-15" />
			<publisher>American Thoracic Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Improvement of Asthma After Administration of Pioglitazone</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Hashimoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Nakahara</surname></persName>
		</author>
		<idno type="DOI">10.2337/diacare.25.2.401</idno>
		<idno type="PMID">11815521</idno>
		<ptr type="open-access" target="http://care.diabetesjournals.org/content/25/2/401.1.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<title level="j" type="abbrev">Diabetes Care</title>
		<idno type="ISSN">0149-5992</idno>
		<idno type="ISSNe">1935-5548</idno>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="401" to="401" />
			<date type="published" when="2002-02-01" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Bronchodilatory Effect of the PPAR-γ Agonist Rosiglitazone in Smokers With Asthma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Spears</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Donnelly</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Jolly</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Brannigan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Mcsharry</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Lafferty</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Chaudhuri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Braganza</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Bareille</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Sweeney</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">M</forename><surname>Adcock</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Barnes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">C</forename><surname>Thomson</surname></persName>
		</author>
		<idno type="DOI">10.1038/clpt.2009.41</idno>
		<idno type="PMID">19357642</idno>
	</analytic>
	<monogr>
		<title level="j">Clinical Pharmacology &amp; Therapeutics</title>
		<title level="j" type="abbrev">Clin Pharmacol Ther</title>
		<idno type="ISSN">0009-9236</idno>
		<idno type="ISSNe">1532-6535</idno>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="49" to="53" />
			<date type="published" when="2009-04-08" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Modulation of Airway Remodeling and Airway Inflammation by Peroxisome Proliferator-Activated Receptor in a Murine Model of Toluene Diisocyanate-Induced Asthma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">R</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">H</forename><surname>Min</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">M</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">C</forename><surname>Lee</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.177.8.5248</idno>
		<idno type="PMID">17015710</idno>
		<ptr type="open-access" target="http://www.jimmunol.org/content/jimmunol/177/8/5248.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Immunology</title>
		<title level="j" type="abbrev">The Journal of Immunology</title>
		<idno type="ISSN">0022-1767</idno>
		<idno type="ISSNe">1550-6606</idno>
		<imprint>
			<biblScope unit="volume">177</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="5248" to="5257" />
			<date type="published" when="2006-10-02" />
			<publisher>The American Association of Immunologists</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">An inverse relationship between peroxisome proliferator–activated receptor γ and allergic airway inflammation in an allergen challenge model</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michiko</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mary</forename><forename type="middle">Jane</forename><surname>Thomassen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Todd</forename><surname>Rambasek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tracey</forename><forename type="middle">L</forename><surname>Bonfield</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Baisakhi</forename><surname>Raychaudhuri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anagha</forename><surname>Malur</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aaron</forename><forename type="middle">R</forename><surname>Winkler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Barbara</forename><forename type="middle">P</forename><surname>Barna</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Samuel</forename><forename type="middle">J</forename><surname>Goldman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mani</forename><forename type="middle">S</forename><surname>Kavuru</surname></persName>
		</author>
		<idno type="DOI">10.1016/s1081-1206(10)61173-8</idno>
		<idno type="PMID">16312170</idno>
	</analytic>
	<monogr>
		<title level="j">Annals of Allergy, Asthma &amp; Immunology</title>
		<title level="j" type="abbrev">Annals of Allergy, Asthma &amp; Immunology</title>
		<idno type="ISSN">1081-1206</idno>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="468" to="473" />
			<date type="published" when="2005-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Epigenetic regulation of adipogenesis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Melina</forename><forename type="middle">M</forename><surname>Musri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marcelina</forename><surname>Párrizas</surname></persName>
		</author>
		<idno type="DOI">10.1097/mco.0b013e3283546fba</idno>
		<idno type="PMID">22617562</idno>
	</analytic>
	<monogr>
		<title level="j">Current Opinion in Clinical Nutrition and Metabolic Care</title>
		<title level="j" type="abbrev">Current Opinion in Clinical Nutrition and Metabolic Care</title>
		<idno type="ISSN">1363-1950</idno>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="342" to="349" />
			<date type="published" when="2012-07" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Leptin inhibits rosiglitazone-induced adipogenesis in murine primary adipocytes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sang</forename><forename type="middle">Dal</forename><surname>Rhee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoon-Young</forename><surname>Sung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Won</forename><forename type="middle">Hoon</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hyae</forename><forename type="middle">Gyeong</forename><surname>Cheon</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.mce.2008.08.018</idno>
		<idno type="PMID">18790715</idno>
	</analytic>
	<monogr>
		<title level="j">Molecular and Cellular Endocrinology</title>
		<title level="j" type="abbrev">Molecular and Cellular Endocrinology</title>
		<idno type="ISSN">0303-7207</idno>
		<imprint>
			<biblScope unit="volume">294</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="61" to="69" />
			<date type="published" when="2008-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">The Effects of Leptin on Airway Smooth Muscle Responses</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Parameswaran</forename><surname>Nair</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Katherine</forename><surname>Radford</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Adrian</forename><surname>Fanat</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Luke</forename><forename type="middle">J</forename><surname>Janssen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marc</forename><surname>Peters-Golden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">Gerard</forename><surname>Cox</surname></persName>
		</author>
		<idno type="DOI">10.1165/rcmb.2007-0091oc</idno>
		<idno type="PMID">18421018</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Respiratory Cell and Molecular Biology</title>
		<title level="j" type="abbrev">Am J Respir Cell Mol Biol</title>
		<idno type="ISSN">1044-1549</idno>
		<idno type="ISSNe">1535-4989</idno>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="475" to="481" />
			<date type="published" when="2008-10" />
			<publisher>American Thoracic Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">The Expression of Adiponectin Receptors and the Effects of Adiponectin and Leptin on Airway Smooth Muscle Cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joo</forename><forename type="middle">Hwa</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jung</forename><forename type="middle">Ho</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Won</forename><forename type="middle">Young</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jung</forename><forename type="middle">Yeon</forename><surname>Shim</surname></persName>
		</author>
		<idno type="DOI">10.3349/ymj.2008.49.5.804</idno>
		<idno type="PMID">18972601</idno>
		<idno type="PMCID">PMC2615381</idno>
		<ptr type="open-access" target="http://synapse.koreamed.org/Synapse/Data/PDFData/0069YMJ/ymj-49-804.pdf" />
	</analytic>
	<monogr>
		<title level="j">Yonsei Medical Journal</title>
		<title level="j" type="abbrev">Yonsei Med J</title>
		<idno type="ISSN">0513-5796</idno>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">804</biblScope>
			<date type="published" when="2008" />
			<publisher>Yonsei University College of Medicine (KAMJE)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Obesity, adiponectin and vascular inflammatory disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Noriyuki</forename><surname>Ouchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shinji</forename><surname>Kihara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tohru</forename><surname>Funahashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuji</forename><surname>Matsuzawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenneth</forename><surname>Walsh</surname></persName>
		</author>
		<idno type="DOI">10.1097/00041433-200312000-00003</idno>
		<idno type="PMID">14624132</idno>
	</analytic>
	<monogr>
		<title level="j">Current Opinion in Lipidology</title>
		<title level="j" type="abbrev">Current Opinion in Lipidology</title>
		<idno type="ISSN">0957-9672</idno>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="561" to="566" />
			<date type="published" when="2003-12" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Augmented responses to ozone in obese carboxypeptidase E-deficient mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">A</forename><surname>Johnston</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Todd</forename><forename type="middle">A</forename><surname>Theman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephanie</forename><forename type="middle">A</forename><surname>Shore</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajpregu.00306.2005</idno>
		<idno type="PMID">16002559</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Physiology-Regulatory, Integrative and Comparative Physiology</title>
		<title level="j" type="abbrev">American Journal of Physiology-Regulatory, Integrative and Comparative Physiology</title>
		<idno type="ISSN">0363-6119</idno>
		<idno type="ISSNe">1522-1490</idno>
		<imprint>
			<biblScope unit="volume">290</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="R126" to="R133" />
			<date type="published" when="2006-01" />
			<publisher>American Physiological Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Obesity-induced inflammatory changes in adipose tissue</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kathryn</forename><forename type="middle">E</forename><surname>Wellen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gökhan</forename><forename type="middle">S</forename><surname>Hotamisligil</surname></persName>
		</author>
		<idno type="DOI">10.1172/jci200320514</idno>
		<ptr type="open-access" target="http://www.jci.org/articles/view/20514/files/pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Investigation</title>
		<title level="j" type="abbrev">J. Clin. Invest.</title>
		<idno type="ISSN">0021-9738</idno>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1785" to="1788" />
			<date type="published" when="2003-12-15" />
			<publisher>American Society for Clinical Investigation</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Effect of Imatinib on Airway Smooth Muscle Thickening in a Murine Model of Chronic Asthma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chin</forename><forename type="middle">Kook</forename><surname>Rhee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jin</forename><forename type="middle">Woo</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chan</forename><forename type="middle">Kwon</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joo</forename><forename type="middle">Sang</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ji</forename><forename type="middle">Young</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Seung</forename><forename type="middle">Joon</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Seok</forename><forename type="middle">Chan</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Soon</forename><forename type="middle">Suk</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Young</forename><forename type="middle">Kyoon</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sung</forename><forename type="middle">Hak</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sook</forename><forename type="middle">Young</forename><surname>Lee</surname></persName>
		</author>
		<idno type="DOI">10.1159/000321261</idno>
		<idno type="PMID">21293142</idno>
	</analytic>
	<monogr>
		<title level="j">International Archives of Allergy and Immunology</title>
		<title level="j" type="abbrev">Int Arch Allergy Immunol</title>
		<idno type="ISSN">1018-2438</idno>
		<idno type="ISSNe">1423-0097</idno>
		<imprint>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="243" to="251" />
			<date type="published" when="2011" />
			<publisher>S. Karger AG</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">PPARγ agonists diminish serum VEGF elevation in diet-induced insulin resistant SD rats and ZDF rats</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Baichun</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peiyuan</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kevin</forename><forename type="middle">M</forename><surname>Carrick</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Judi</forename><forename type="middle">A</forename><surname>Mcnulty</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lisa</forename><forename type="middle">G</forename><surname>Clifton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Deborah</forename><forename type="middle">A</forename><surname>Winegar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jay</forename><forename type="middle">C</forename><surname>Strum</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephen</forename><forename type="middle">A</forename><surname>Stimpson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Greg</forename><forename type="middle">L</forename><surname>Pahel</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbrc.2005.06.078</idno>
		<idno type="PMID">15993383</idno>
	</analytic>
	<monogr>
		<title level="j">Biochemical and Biophysical Research Communications</title>
		<title level="j" type="abbrev">Biochemical and Biophysical Research Communications</title>
		<idno type="ISSN">0006-291X</idno>
		<imprint>
			<biblScope unit="volume">334</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="176" to="182" />
			<date type="published" when="2005-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Okuno</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Tamemoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Tobe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Ueki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Mori</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Iwamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Umesono</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Akanuma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Fujiwara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Horikoshi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Yazaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Kadowaki</surname></persName>
		</author>
		<idno type="DOI">10.1172/jci1235</idno>
		<idno type="PMID">9502777</idno>
		<idno type="PMCID">PMC508690</idno>
		<ptr type="open-access" target="http://www.jci.org/articles/view/1235/files/pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Investigation</title>
		<title level="j" type="abbrev">J. Clin. Invest.</title>
		<idno type="ISSN">0021-9738</idno>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1354" to="1361" />
			<date type="published" when="1998-03-15" />
			<publisher>American Society for Clinical Investigation</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
